. We expected that these myocardial slices would be virtually free from the mechanical constraints that they had in situ. Using this new preparation, we have revealed that an increment in V O 2 by 1-Hz stimulation consists of V O 2 for Ca 2ϩ handling in the excitation-contraction (E-C) coupling (E-C coupling V O 2 ) but not for residual crossbridge cycling. We also have revealed that V O 2 without stimulation represents a constant basal metabolism (basal metabolic V O 2 ) in both normal and Ca 2ϩ -free Tyrode solution (29, 36) . However, the energy expenditure due to the increase in cross-bridge cycling of these myocardial slices remains to be analyzed.
WE HAVE INSTITUTED rat left ventricular (LV) slices (300 µm thick) in a perfusion and electrical stimulation chamber as an appropriate preparation to analyze myocardial O 2 consumption (V O 2 ) under mechanically unloaded conditions (29, 31, 36) . We expected that these myocardial slices would be virtually free from the mechanical constraints that they had in situ. Using this new preparation, we have revealed that an increment in V O 2 by 1-Hz stimulation consists of V O 2 for Ca 2ϩ handling in the excitation-contraction (E-C) coupling (E-C coupling V O 2 ) but not for residual crossbridge cycling. We also have revealed that V O 2 without stimulation represents a constant basal metabolism (basal metabolic V O 2 ) in both normal and Ca 2ϩ -free Tyrode solution (29, 36) . However, the energy expenditure due to the increase in cross-bridge cycling of these myocardial slices remains to be analyzed.
The aim of the present study was, first, to detect an increase in energy expenditure or V O 2 due to the increase in cross-bridge cycling by Ba 2ϩ contracture of myocardial slices from the rat LV. Our second goal was to analyze the mechanism of the increased V O 2 by using a sarcoplasmic reticulum (SR) Ca 2ϩ -pump blocker, cyclopiazonic acid (CPA) (2, 29) , and a cross-bridge cycling inhibitor, 2,3-butanedione monoxime (29, 36) .
There is no direct evidence indicating whether Ba 2ϩ exclusively activates the contractile system (4, 13, 17, 22, 23) . Because Ba 2ϩ contracture is induced by displacing Ca 2ϩ with Ba 2ϩ , an incomplete washout of Ca 2ϩ during the superfusion with nominally Ca 2ϩ -free Tyrode solution may be one possibility. Although we have previously reported that E-C coupling V O 2 is not detected in nominally Ca 2ϩ -free Tyrode solution, even when electrical stimulation is performed (36) , the possibility that Ba 2ϩ releases residual Ca 2ϩ from the SR via a mechanism similar to the Ca 2ϩ -induced Ca 2ϩ -release mechanism (5, 6) should be considered. However, there is little supporting evidence for this possibility (13, 25) . To the contrary, there is evidence that Ba 2ϩ blocks SR Ca 2ϩ release in triadic SR preparations, even though these preparations are isolated from skeletal muscle (19, 20) . Although there is another possibility that Ba 2ϩ is sequestered and released (i.e., cycled) by the SR, just as Ca 2ϩ and Sr 2ϩ are (26) , many studies have suggested that Ba 2ϩ is not cycled (1, 9, 14, 15, 19, 32) . Displacing Ca 2ϩ with Ba 2ϩ can activate contractile protein interactions, but it does not support E-C coupling in skeletal muscle (9) . Furthermore, Ba 2ϩ has no effect on SR Ca 2ϩ ATPase activity in skeletal muscle SR (14) and myocardial SR (1) and on Ca 2ϩ uptake by skeletal muscle SR (15, 19, 32) . In agreement with these studies suggesting the lack of Ba 2ϩ cycling in SR, we obtained results of the energetics to reveal that the V O 2 of Ba 2ϩ -activated myocardial slices was mainly used for the cross-bridge cycling but not for the residual Ca 2ϩ handling by the SR Ca 2ϩ pump.
METHODS

LV Myocardial Slice Preparation
Forty-one adult male crj:Wistar rats weighing 300-420 g (mean weight 358 Ϯ 29 g) were purchased from Charles River Japan (Yokohama, Japan) and anesthetized with pentobarbital sodium (50 mg/kg ip). All experimental procedures were described previously in detail (29, 36) . Briefly, the whole heart was excised after perfusion with Tyrode solution at 12°C gassed with 100% O 2 for 5-10 min. The composition of Tyrode solution (in mmol/l) was 136.0 NaCl, 5.4 KCl, 1.0 MgCl 2 ·6H 2 O, 0.33 NaH 2 PO 4 ·2H 2 O, 0.9 CaCl 2 ·2H 2 O, 10.0 glucose, and 5.0 HEPES, with pH corrected to 7.4 with NaOH at 30°C. Each myocardial slice was cut into 300-µm-thick slices in parallel with the epicardium with a microslicer (DTK-3000; Dosaka EM, Kyoto, Japan). We obtained 17-24 slices from each
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heart. The slices were stored for 30 min in 18°C Tyrode and then for at least 
Assessment of V O 2 of Myocardial Slices
We first examined the background V O 2 with no myocardial slices in the Tyrode-filled chamber at the beginning and end . We determined the wet weight of each set of slices [58.7 Ϯ 13.5 mg; n ϭ52 sets of slices] so that the ratio of B to A became higher than 2.0. The maximum sensitivity of the O 2 measurement was obtained when B/A was 2.0, i.e., 0.92 µl O 2 /min in this chamber. We have previously confirmed that the myocardial slice V O 2 was reproducible in three repeated measurements in the same protocol without stimulation at 30°C (29) .
Experimental Protocol
Any Tyrode solutions were gassed with 100% O 2 and preheated to 30°C in a water bath. Six slices on average were placed in the air-tight chamber filled with the prepared 2.62 Ϯ 0.04 ml (n ϭ 52 sets of slices) Tyrode solution gassed with 100% O 2 . These slices were preincubated and then incubated in Ca 2ϩ -free Tyrode solution without and with Ba 2ϩ throughout the experiment. E-C coupling V O 2 was not detected under these conditions, even when electrical stimulation was performed (36) . Myocardial V O 2 of Ba 2ϩ -activated slices without electrical stimulation was not different from that with stimulation. Therefore, we measured the V O 2 of all slices without stimulation. We used the following protocols in four different groups of slices. Protocol 1. There were 31 sets of slices from 20 rats in protocol 1. After 10-min incubation of a set of slices in Ca 2ϩ -free Tyrode solution, the first V O 2 measurement was performed for 6 min. This value was used as a control value. After the first washout of the slices with Ba 2ϩ Tyrode solution for 10 min, the second V O 2 measurement of Ba 2ϩ -activated slices in this solution was performed for 6 min. The concentration of Ba 2ϩ was increased from 0.3 (n ϭ 6), 0.5 (n ϭ 10), and 1 (n ϭ 6) mmol/l to 3 mmol/l (n ϭ 9). After the V O 2 of Ba 2ϩ -activated slices was measured, the slices were washed out with Ca 2ϩ -free Tyrode solution for 10 min and the V O 2 of the noncontracted slices was measured for 6 min. These values were used as back control values.
Protocol 2. Eight sets of slices from eight rats were used in protocol 2. To confirm the stability of V O 2 of Ba 2ϩ -activated slices, the V O 2 was repeatedly measured in the same set of slices after the measurement of V O 2 of the slices in Ca 2ϩ -free Tyrode solution. After 10-min incubation of a set of slices in Ca 2ϩ -free Tyrode solution, the first V O 2 measurement was performed for 6 min. This value was used as a control value. After the washout of the slices with Ba 2ϩ Tyrode solution for 10 min, the second V O 2 measurement of Ba 2ϩ -activated slices in this solution was performed for 6 min. The concentration of Ba 2ϩ was 1 mmol/l. After the V O 2 of Ba 2ϩ -activated slices was measured, the activated slices were again superfused with Ba 2ϩ Tyrode solution for 5 or 10 min and the third V O 2 measurement was performed for 6 min. Total time of treatment with Ba 2ϩ was at least 27-32 min.
Protocol 3. Seven sets of slices from seven rats were used in protocol 3, and CPA (10 µmol/l) in 1.3% dimethyl sulfoxide was used as a vehicle. Control values were obtained as in protocol 1. After washout of the slices with Ba 2ϩ (1 mmol/l) Tyrode solution for 10 min, the second V O 2 measurement of Ba 2ϩ -activated slices was performed for 6 min. This value was used as the Ba 2ϩ (1 mmol/l) V O 2 value. Pretreatment of CPA (10 µmol/l) in Ca 2ϩ -free Tyrode solution for 5 min completely blocked Ba 2ϩ contracture by Ba 2ϩ (1 mmol/l) Tyrode solution in the presence of CPA (10 µmol/l) for 10 min (unpublished observation). Therefore, we added CPA (10 µmol/l) after the second V O 2 measurement of Ba 2ϩ -activated slices as follows: after washout of the slices with Ba 2ϩ (1 mmol/l) Tyrode solution containing CPA (10 µmol/l) for 5 min, the third V O 2 measurement in this solution was performed for 6 min. This value was used as the CPA V O 2 value. To confirm the recovery from activation with Ba 2ϩ (1 mmol/l) Tyrode solution containing CPA (10 µmol/l) after the third measurement, four of the seven sets of slices were washed out with Ca 2ϩ -free Tyrode solution for 10 min and the V O 2 of the same slices was measured for 6 min. These values were used as back control values. 
Statistics
All data are presented as means Ϯ SD. Data were analyzed by one-way and repeated-measures ANOVA and followed, as necessary, by multiple comparisons using Bonferroni (29, 36) . The observed full recovery from Ba 2ϩ -induced increase in V O 2 of myocardial slices was in accordance with the results obtained in the superfused papillary muscle and Langendorff-perfused heart; the Ba 2ϩ contracture was attenuated as the Ba 2ϩ was washed out of the cardiac cells when Ba 2ϩ Tyrode solution was displaced by normal Tyrode solution (17, 23) .
Concentration Dependence of Ba 2ϩ Activation of Slice V O 2
The pooled control V O 2 values of quiescent slices and back control of the same slices in Ca 2ϩ -free Tyrode solution were almost constant at 2.25 Ϯ 0.54 ml O 2 · min Ϫ1 ·100 g LV Ϫ1 in all series of protocol 1. As shown in Fig. 1 , the V O 2 values of the slices activated by Ba 2ϩ increased in a dose-dependent manner from 110% of control at 0.3 mmol/l Ba 2ϩ (n ϭ 6) to 150% of control at 3 mmol/l Ba 2ϩ (n ϭ 9). The V O 2 significantly increased from that at 0.5 mmol/l Ba 2ϩ (P Ͻ 0.05) and gradually increased up to that at 3 mmol/l Ba 2ϩ . However, the V O 2 at 3 mmol/l Ba 2ϩ did not significantly increase from that at 1 mmol/l Ba 2ϩ (P Ͼ 0.05). Therefore, we used 1 mmol/l Ba 2ϩ in protocols 2-4.
Constancy of Repeated Measurement of V O 2 Value in Ba 2ϩ -Activated Slices
In protocol 2, after the V O 2 of the quiescent slices was measured in Ca 2ϩ -free Tyrode solution (2.55 Ϯ 0. 
Effects of CPA on V O 2 of Ba 2ϩ -Activated Slices
The control V O 2 in Ca 2ϩ -free Tyrode solution was 2.30 Ϯ 0.61 ml O 2 · min Ϫ1 ·100 g LV Ϫ1 . The V O 2 of Ba 2ϩ -activated slices significantly increased to 141.5 Ϯ 12.1% of the control V O 2 (P Ͻ 0.05) (Fig. 2) . The V O 2 of Ba 2ϩ -activated slices treated with CPA was 142.1 Ϯ 14.1% of the control V O 2 (Fig. 2) . Thus CPA did not decrease the V O 2 of Ba 2ϩ -activated slices (P Ͼ 0.05). To confirm the recovery of Ba 2ϩ -activated slices treated with CPA, the slices were washed out with Ca 2ϩ -free Tyrode solution and the fourth V O 2 of the same slices in the absence of extracellular Ba 2ϩ was measured (n ϭ 4). The fourth V O 2 of the slices was 2.13 Ϯ 0.60 ml O 2 · min Ϫ1 ·100 g LV Ϫ1 (n ϭ 4). The first V O 2 of basal metabolism was 1.95 Ϯ 0.59 ml O 2 · min Ϫ1 ·100 g LV Ϫ1 . These values were not significantly different from each other (P Ͼ 0.05). 
Effects of BDM on V O 2 of Ba 2ϩ -Activated Slices
The V O 2 of Ba 2ϩ -activated slices was significantly (P Ͻ 0.05) reduced from 141.8 Ϯ 21.3 to 110.1 Ϯ 6.7% of the control V O 2 value (2.23 Ϯ 0.56 ml O 2 · min Ϫ1 · 100 g LV Ϫ1 ) by treatment with BDM (Fig. 3) .
DISCUSSION
The most important results are 1) our method for measurement of myocardial V O 2 using mechanically unloaded myocardial slices from rat LV (29, 36) showed a stable and reversible increase in V O 2 due to Ba 2ϩ contracture similar to that in Langendorff-perfused hearts and superfused papillary muscle (17, 23, 24) ; 2) the increase in V O 2 by Ba 2ϩ was dose dependent between 0.3 and 3 mmol/l; 3) the increased V O 2 was not reduced by the SR Ca 2ϩ pump inhibitor CPA (10 µmol/l); and 4) the increased V O 2 was, however, reduced by the cross-bridge cycling inhibitor BDM (5 mmol/l). Therefore, an increase in V O 2 by Ba 2ϩ contracture was due to increased cross-bridge cycling but not due to increased Ca 2ϩ handling in E-C coupling mainly used for the SR Ca 2ϩ pump (29) .
A New Approach of LV Mechanoenergetics Using Mechanically Unloaded Myocardial Slices
We and others have already reported a linear myocardial V O 2 systolic pressure-volume area (a total mechanical energy) from the curved end-systolic pressurevolume relation in the rat LV in the blood-perfused whole heart preparation (10, 11, 31, 33) , similar to that in canine and rabbit hearts (8, 18, 27, 28, 30) . The V O 2 intercept of this relation (minimally loaded V O 2 , not mechanically unloaded V O 2 ) is mainly composed of the E-C coupling V O 2 and basal metabolic V O 2 (10, 11, 31) . However, the V O 2 -intercept may include the V O 2 residual cross-bridge cycling (12, 34) . Therefore, we have proposed a new approach for evaluating the mechanically unloaded V O 2 using myocardial slices.
Recently, we have reported that BDM (5 mmol/l) markedly attenuated the 1-Hz twitch-free shortening of mechanically unloaded myocardial slices by 78% of control but did not decrease E-C coupling V O 2 (29, 34, 36) . This indicates that the V O 2 for the residual crossbridge cycling during mechanically unloaded twitches was negligibly small (29, 36) . However, when crossbridge cycling is enhanced, the V O 2 for its cycling could be detected. Actually, we obtained the expected results in the present study; the V O 2 during Ba 2ϩ contracture of myocardial slices increased with Ba 2ϩ concentration in a dose-dependent manner. This increase is due to the increase in V O 2 for cross-bridge cycling, because E-C coupling V O 2 is almost completely abolished in Ca 2ϩ -free Tyrode solution (36) . From these results, we conclude that the energy expenditure of myocardial slices during 1-Hz twitch-free shortening is composed of the E-C coupling and basal metabolic V O 2 but is not composed of the detectable V O 2 for the cross-bridge cycling.
Basal metabolism after KCl arrest is ϳ20 µl O 2 · min Ϫ1 · g Ϫ1 (0.02 ml O 2 · min Ϫ1 · g Ϫ1 ) in an intact rat heart (11) . On the other hand, basal metabolic V O 2 (in Ca 2ϩ -free medium) of rat myocardial slices (mechanically unloaded) was ϳ2.3 ml O 2 · min Ϫ1 · 100 g Ϫ1 (0.023 ml O 2 · min Ϫ1 · g Ϫ1 ) in the present study. Therefore, the basal metabolic V O 2 in rat myocardial slices (29, 36) is nearly equal to that in an intact heart (11). This value is greater than that in dogs and rabbits (11, 18, 29, 36) . We have previously reported a lack of suppression of basal metabolism by SR Ca 2ϩ -ATPase inhibitors (29) . From these results, we have already suggested energyconsuming (wasting) processes, such as protein synthesis, other than those at the SR as the possible underlying mechanism for the greater basal metabolism in the rat myocardium (29) .
V O 2 of Ba 2ϩ -Activated Slices
The present results revealed for the first time that Ba 2ϩ increased the V O 2 of myocardial slices in a dosedependent manner. These findings are reasonable considering the mechanism of Ba 2ϩ contracture; Ba 2ϩ interacts with troponin C binding site like Ca 2ϩ , in a dose-dependent manner, and allows cross-bridge formation (21-24), i.e., an increase in energy expenditure due to an enhanced number of cross-bridge cycles of attachment and detachment (35) .
In the present experiment, the V O 2 began to increase by 10% (0.2 ml O 2 · min Ϫ1 ·100 g LV Ϫ1 ) of the control V O 2 of quiescent slices at 0.3 mmol/l of Ba 2ϩ , and it gradually increased up to that at 3 mmol/l Ba 2ϩ . The Ba 2ϩ contracture of the slice was also confirmed by the microscopic observation in the present experiment. Although the steady isometric tension increased as Ba 2ϩ increased from ϳ1 µmol/l to 0.1 mmol/l in the glycerinated skinned papillary muscle (22) , the effec- (24) .
The V O 2 of 1 mmol/l Ba 2ϩ -activated slices pooled from all experiments corresponds to ϳ140% of the control V O 2 in Ca 2ϩ -free Tyrode solution. However, in the rabbit LV preloaded at its end-diastolic pressure of 10 mmHg, mean LV V O 2 during the first 30 min of Ba 2ϩ contracture increased to 3.63 ml O 2 · min Ϫ1 ·100 g LV Ϫ1 (ϳ300% of basal metabolic V O 2 of rabbit cardiac muscle) (24) . Furthermore, Munch et al. (17) have reported a linear increase in LV pressure due to the increase in LV volume during Ba 2ϩ contracture of rabbit hearts. These results suggest that an increase in V O 2 under a preloaded condition would be higher than that under a mechanically unloaded condition even in the myocardium during Ba 2ϩ contracture.
Reversibility and Stability of V O 2 of Slice During Ba 2ϩ Contracture
In the present study, basal metabolic V O 2 of myocardial slices under Ca 2ϩ -free conditions corresponded to that under normal Tyrode conditions without stimulation (7, 29, 36) and that under KCl arrest in the rat heart (11). The V O 2 after washout of 1 mmol/l Ba 2ϩ with Ca 2ϩ -free Tyrode solution returned to the pre-Ba 2ϩ level of V O 2 obtained by the first measurement in Ca 2ϩ -free Tyrode solution. Thus the Ba 2ϩ that enters the cell (16) can be extruded from the myocardium (3, 4) .
From the measurements of ATP and phosphocreatine during Ba 2ϩ contracture, Shibata et al. (24) supported the notion that Ba 2ϩ induces a form of contracture that is quite stable but associated with a minimal energy demand, perhaps primarily for the cross-bridge cycling. In fact, the V O 2 of Ba 2ϩ contracture of mechanically unloaded slices continued for at least 32 min in the present experiment, and the value was constant, corresponding to 130-140% of basal metabolic V O 2 .
Effects of CPA and BDM
Saeki et al. (22, 23) claimed that there is no direct evidence that Ba 2ϩ exclusively activates the contractile system; in fact, they observed that Ba 2ϩ depolarized the membrane potential independently of activating the contractile system. We have already reported that CPA inhibits the V O 2 of the myocardial slices during 1-Hz mechanically unloaded contraction in a dose-dependent manner (1-10 µmol/l); at 10 µmol/l CPA the E-C coupling V O 2 was reduced by 70% (2, 29, 31) . The present results showing no decreases in V O 2 of Ba 2ϩ -activated slices by 10 µmol/l CPA support the postulate that the V O 2 of Ba 2ϩ -activated slices is not primarily consumed by the SR Ca 2ϩ -ATPase. These results, in agreement with many studies on skeletal muscle SR (9, 14, 15, 19, 20, 32) , suggest that Ba 2ϩ is not cycled in SR of the rat myocardium and does not induce the release of residual Ca 2ϩ from SR of the rat myocardium.
In the present study, we used BDM (5 mmol/l) to inhibit cross-bridge cycling. We have already confirmed that this concentration of BDM did not affect either the E-C coupling or basal metabolic V O 2 of the myocardial slices (36) . BDM (5 mmol/l) decreased V O 2 during Ba 2ϩ contracture approximately to the basal metabolic V O 2 level, suggesting the possibility that the increase in V O 2 by Ba 2ϩ contracture exclusively derived from the increased cross-bridge cycling. Taking the CPA and BDM data together, we conclude that the increase in V O 2 of Ba 2ϩ -activated slices is not due to SR Ca 2ϩ -ATPase but is primarily due to cross-bridge cycling.
